Monthly archives for March, 2021
Latest Research Reports On Stocks By Leading Brokerages: If you have any research reports that you would like to share with us, please send it to michael@rakesh-jhunjhunwala.in or to admin@rakesh-jhunjhunwala.in. (The pre-June 2016 reports are available here).
| Gland Pharma Initiating Coverage Research Report By Axis Securities | |
| Company: | Gland Pharma Ltd |
| Brokerage: | Axis Securities |
| Date of report: | March 9, 2021 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 15% |
| Summary: | Well-positioned to Capitalise Fast-growing Generic Injectibles Market |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Axis Securities, Gland Pharma Ltd |
| NIFTY Target Upgraded To 17,200 + Best 15 Stocks To Buy Now: Axis Securities Report | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | March 2, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 36% |
| Summary: | Structural trends intact; Upgrade Nifty Target to 17,200 |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Axis Securities, Model Portfolio |